These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25913648)

  • 21. Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
    Price J; Cheek E; Lippett S; Cubbon M; Gerding DN; Sambol SP; Citron DM; Llewelyn M
    Clin Microbiol Infect; 2010 Aug; 16(8):1297-302. PubMed ID: 19832710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of environmental decontamination using hydrogen peroxide vapour on the incidence of Clostridium difficile infection in one hospital Trust.
    Cooper T; O'Leary M; Yezli S; Otter JA
    J Hosp Infect; 2011 Jul; 78(3):238-40. PubMed ID: 21392849
    [No Abstract]   [Full Text] [Related]  

  • 23. Effectiveness of deep cleaning followed by hydrogen peroxide decontamination during high Clostridium difficile infection incidence.
    Best EL; Parnell P; Thirkell G; Verity P; Copland M; Else P; Denton M; Hobson RP; Wilcox MH
    J Hosp Infect; 2014 May; 87(1):25-33. PubMed ID: 24746230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.
    Baur D; Gladstone BP; Burkert F; Carrara E; Foschi F; Döbele S; Tacconelli E
    Lancet Infect Dis; 2017 Sep; 17(9):990-1001. PubMed ID: 28629876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of Infection due to Clostridium (Clostridioides) difficile.
    Krishna A; Chopra T
    Infect Dis Clin North Am; 2021 Dec; 35(4):995-1011. PubMed ID: 34752229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital.
    Kallen AJ; Thompson A; Ristaino P; Chapman L; Nicholson A; Sim BT; Lessa F; Sharapov U; Fadden E; Boehler R; Gould C; Limbago B; Blythe D; McDonald LC
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):264-72. PubMed ID: 19215193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A targeted strategy to wipe out Clostridium difficile.
    Orenstein R; Aronhalt KC; McManus JE; Fedraw LA
    Infect Control Hosp Epidemiol; 2011 Nov; 32(11):1137-9. PubMed ID: 22011546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms.
    Sitzlar B; Deshpande A; Fertelli D; Kundrapu S; Sethi AK; Donskey CJ
    Infect Control Hosp Epidemiol; 2013 May; 34(5):459-65. PubMed ID: 23571361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of cleaning and other interventions on the reduction of hospital-acquired Clostridium difficile infections in two hospitals in England assessed using a breakpoint model.
    Hughes GJ; Nickerson E; Enoch DA; Ahluwalia J; Wilkinson C; Ayers R; Brown NM
    J Hosp Infect; 2013 Jul; 84(3):227-34. PubMed ID: 23787167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy.
    van Kleef E; Deeny SR; Jit M; Cookson B; Goldenberg SD; Edmunds WJ; Robotham JV
    Vaccine; 2016 Nov; 34(46):5562-5570. PubMed ID: 27727031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction in the incidence of hospital-acquired Clostridium difficile infection through infection control interventions other than the restriction of antimicrobial use.
    You E; Song H; Cho J; Lee J
    Int J Infect Dis; 2014 May; 22():9-10. PubMed ID: 24583565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term effect of infection control practices and associated factors during a major Clostridium difficile outbreak in Costa Rica.
    Wong-McClure RA; Ramírez-Salas E; Mora-Brenes N; Aguero-Sandí L; Morera-Sigler M; Badilla-Vargas X; Hernández-de Merzerville M; O'Shea M; Bryce E
    J Infect Dev Ctries; 2013 Dec; 7(12):914-21. PubMed ID: 24334937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of Clostridium difficile infection in rural hospitals.
    Haun N; Hofer A; Greene MT; Borlaug G; Pritchett J; Scallon T; Safdar N
    Am J Infect Control; 2014 Mar; 42(3):311-5. PubMed ID: 24406257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.
    Yeung SS; Yeung JK; Lau TT; Forrester LA; Steiner TS; Bowie WR; Bryce EA
    J Clin Pharm Ther; 2015 Dec; 40(6):655-60. PubMed ID: 26547905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridium difficile control measures: current and future methods for prevention.
    Mejia-Chew C; Dubberke ER
    Expert Rev Anti Infect Ther; 2018 Feb; 16(2):121-131. PubMed ID: 29353504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A bundle strategy including patient hand hygiene to decrease clostridium difficile infections.
    Pokrywka M; Feigel J; Douglas B; Grossberger S; Hensler A; Hensler A; Weber D
    Medsurg Nurs; 2014; 23(3):145-8, 164. PubMed ID: 25137788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures.
    Salgado CD; Mauldin PD; Fogle PJ; Bosso JA
    Am J Infect Control; 2009 Aug; 37(6):458-64. PubMed ID: 19243859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of Infection Due to Clostridium difficile.
    Cooper CC; Jump RL; Chopra T
    Infect Dis Clin North Am; 2016 Dec; 30(4):999-1012. PubMed ID: 27660089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ASID/ACIPC position statement - Infection control for patients with Clostridium difficile infection in healthcare facilities.
    Stuart RL; Marshall C; Harrington G; Sasko L; McLaws ML; Ferguson J
    Infect Dis Health; 2019 Feb; 24(1):32-43. PubMed ID: 30691583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.